| Harvey J Kliman, MD | |
|
150 Sargent Dr, New Haven, CT 06511-6100 | |
| (203) 785-4708 | |
| (203) 785-4914 |
| Full Name | Harvey J Kliman |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 150 Sargent Dr, New Haven, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124001912 | NPI | - | NPPES |
| 001315606 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 031560 (Connecticut) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 031560 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Harvey J Kliman, MD Po Box 9805, 300 George St 6th Floor, New Haven, CT 06536-0805 Ph: () - | Harvey J Kliman, MD 150 Sargent Dr, New Haven, CT 06511-6100 Ph: (203) 785-4708 |
News Archive
Anti-osteoporotic medication is not an effective means for preventing hip fractures among the elderly, concludes a study recently published in the BMJ. According to Professor Teppo Järvinen from the University of Helsinki, who heads the research group, the prevalent assumption that brittle bones cause hip fractures is fundamentally flawed.
A non-pathogenic bacterium is capable to trigger an autoimmune disease similar to the multiple sclerosis in the mouse, the model animal which helps to explain how human diseases work. This is what a group of researchers from the Catholic University of Rome, led by Francesco Ria (Institute of General Pathology) and Giovanni Delogu (Institute of Microbiology), have explained for the first time in a recently published article on the Journal of Immunology.
Johns Hopkins investigators are testing a way to use drugs that target a cholesterol pathway to enhance the cancer-killing potential of standard chemotherapy drugs. Their tests, in mouse models of pancreatic cancer, may yield new and more effective combinations of current and possibly new anti-cancer drugs.
Businesses in the United States are focusing a large portion of their research and development efforts on health and defense, according to a National Science Foundation (NSF) report released today.
› Verified 7 days ago
Dr. Barton Charles Kenney, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 20 York Street, T-209, Yale-new Haven Hospital, New Haven, CT 06510 Phone: 203-688-2259 Fax: 203-688-5599 | |
Edward S Lee, MD, PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Melissa Anne Much, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 20 York St # T-209, Yale-new Haven Hospital, New Haven, CT 06510 Phone: 203-688-2259 Fax: 203-688-5599 | |
Haris Mirza, MD Pathology Medicare: Medicare Enrolled Practice Location: Yale School Of Medicine, Dept. Of Pathology, 20 York St, New Haven, CT 06510 Phone: 877-925-3522 Fax: 203-737-5388 | |
Raffaella Morotti, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 310 Cedar St, Pathology Department, New Haven, CT 06510 Phone: 203-737-6325 | |
Dr. Richard Rodion Rathbone, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 20 York St, Yale-new Haven Hospital, New Haven, CT 06504 Phone: 203-688-2439 Fax: 203-688-5103 | |
Dr. Mahboubeh Rahmani, MD Pathology Medicare: Medicare Enrolled Practice Location: 310 Cedar St, New Haven, CT 06510 Phone: 203-737-2115 |